Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-08-12
1993-03-09
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514317, 514318, 514319, 514321, 514328, 514326, A61K 31445
Patent
active
051927721
ABSTRACT:
Compounds are described which are useful for lowering the activity of .alpha..sub.2 -PI, for the treatment of myocardial infarctions and cerebral infarctions, as urokinase secretion accelerators, as antithrombotic agents and to accelerate the fibrinolysis accelerating effect.
REFERENCES:
patent: 4182767 (1980-01-01), Murai et al.
patent: 4260622 (1981-04-01), Junge et al.
patent: 4312872 (1982-01-01), Junge et al.
patent: 4348402 (1982-09-01), Kinast et al.
patent: 4533688 (1985-08-01), Matsumura et al.
patent: 4639436 (1987-01-01), Junge et al.
Blomback et al, Plasma Proteins, 1976, pp. 288-308.
Aoki and Harpel, Seminars in Thrombosis and Hemostasis--vol. 10, No. 1, 1984.
Dictionary of Organic Compounds, 5th Edition, 2nd Supplement. Chapman & Hall, publication 1984.
Mori Kazuya
Ojima Nobutoshi
Yoshikuni Yoshiaki
Nippon Shinyaku Co. Ltd.
Waddell Frederick E.
Weddington K.
LandOfFree
Therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-211727